Pinsent Masons LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Pinsent Masons LLP‘s life sciences and healthcare groups are well-equipped to handle a range of disputes, transactions and regulatory mandates. The firm is particularly well-known for assisting generic companies in patent litigation. Noted for her capabilities advising life sciences clients on various IP, data, FOI and AI issues, Karen Gallagher leads the life sciences team alongside co-head Neil Keenan, who has a wealth of experience handling corporate transactions in the sector, including assisting clients with fundraisings and subsequent exits. With a focus on healthcare transactions, Dorian Rees leads the healthcare offering. Maureen Daly is another key name to note.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘In-depth knowledge of our sector and major players within. Comprehensive background team and experienced partners.’
- ‘Karen Gallagher is responsive, knowledgeable and solutions focused. She provides comprehensive focused and commercial advice.’
Key clients
- Sandoz
- ReproMed
Work highlights
Advising Teva in a dispute challenging the validity of BMS’ compound patent/SPC in respect of apixaban/Eliquis , as well as three sets of related proceedings concerning Eliquis, including compound infringement proceedings, and revocation and infringement proceedings concerning six formulation patents protecting the product.